In addition, we identified key antitumor regulatory and metabolic pathways like nod-like receptor signaling and sphingolipid metabolism in KLF15-induced TNBC inhibition, broadening the range of potential KLF15 mediated tumor inhibiting pathways. The gene discussed is KLF15; the disease is neoplasm.